论文部分内容阅读
目的:探讨布地奈德雾化吸入联合阿奇霉素治疗支原体肺炎的临床疗效。方法:将101例支原体肺炎患儿随机分为两组,对照组50例采用阿奇霉素贯序疗法治疗;治疗组51例在对照组治疗基础上加布地奈德雾化吸入,并对两组临床疗效进行比较。结果:治疗组和对照组总有效率分别为90.20%和72.00%,两组总有效率比较差异有统计学意义(χ2=5.47,P<0.05)。结论:布地奈德雾化吸入联合阿奇霉素治疗支原体肺炎效果显著。
Objective: To investigate the clinical efficacy of budesonide inhalation combined with azithromycin in the treatment of mycoplasma pneumonia. Methods: 101 cases of children with mycoplasma pneumonia were randomly divided into two groups, the control group of 50 cases treated with azithromycin sequential therapy; the treatment group 51 cases in the control group on the basis of inhalation of buprenorphine and nebulization, and the two groups of clinical efficacy Compare. Results: The total effective rates of the treatment group and the control group were 90.20% and 72.00%, respectively. There was significant difference between the two groups in total effective rate (χ2 = 5.47, P <0.05). Conclusion: Budesonide inhalation combined with azithromycin has a significant effect on mycoplasma pneumonia.